Publication | Closed Access

Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients

Prognostic BiomarkersPotential Predictive BiomarkersMedicineImmunologyBlood Mrna ExpressionCancer GenomicsCancer TreatmentOncologyCell BiologyLung CancerCancer ResearchPlatinum-based Chemotherapy